The inhaled corticosteroid (ICS), beclomethasone dipropionate (BDP), attenuated the expression of submucosal MMP-9 and increased that of submucosal TIMP-1, suggesting corticosteroid treatment of asthma to ameliorate angiogenesis [98]. This evidence concerns the gene MMP9 and asthma.